GAS5 and breast cancer: Further study declares that GAS5 is downregulated in SKBR-3/Tr cells and breast cancer tissue from trastuzumab-treated patients, while lapatinib can upregulate GAS5 targeting of PTEN to relieve trastuzumab resistence30.